FindTrial
Sign In

Survey of anti-CGRP monoclonal antibodies in Japan

Survey of anti-CGRP monoclonal antibodies in Japan - Survey of anti-CGRP monoclonal antibodies in Japan

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049149
Enrollment
Unknown
Registered
2022-10-07
Start date
2022-12-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

None listed

Sponsors

Department of Neurology, Keio University School of Medicine
Lead Sponsor
Task force for the use of anti-CGRP monoclonal antibodies, The Japanese Headache Society
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Members of The Japanese Headache Society (Medical Doctors)

Exclusion criteria

Exclusion criteria: Non-medical doctors

Design outcomes

Primary

MeasureTime frame
Criteria for prescribing CGRPmAbs—

Countries

Japan

Contacts

Public ContactTsubasa Takizawa

Keio University School of Medicine Department of Neurology

tsubasa.takizawa@keio.jp0353633788

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026